A Deep Look into Challenges, Gaps and Opportunities within CGT

Join our host Shari Hulitt, Business Manager in Life Science at CSG Talent - On this episode of Conversations with CSG she sits down with Anis-Fahandej-Sadi– the founder of leading biotech and pharma newsletter – TLDR Biotech. 

In this episode Shari delves into Anis’ academic journey and his Masters in Chemistry, his strong experience working across sales and other business functions within biotech and how this led to the founding of TLDR Biotech. 

Anis shares his own experiences of industry updates and digesting large volumes of information and how TLDR Biotech came to fruition, highlighting the importance and benefits this brings both individuals and businesses within the cell and gene therapy space. 

With significant advancements expected in the cell and gene therapy market over the next 12 months, including a growing number of therapy approvals, challenges like affordability and expanding patient access reflect the industry's maturation, alongside other barriers which Anis and Shari delve into further on the episode. 

Anis published a report – Cell & Gene Therapy: A Field at a Crossroads in recent months. Anis shares insights gained through a high volume of interviews with professionals within the CGT space, the main findings from a CGT SWOT analysis he carried out and the impact this will have on the future direction of cell and gene therapy.  

In this insightful conversation, Anis and Shari also discuss skills gaps, demand for talent and the greatest career advice to succeed in your career. 

To learn more about what we discussed, or for further insights into the Life Science industry - Reach out to Shari Hulitt - shari.hulitt@csgtalent.com 

Conversations with CSG - If you're interested in sharing your own insights on our podcast, please get in touch with our marketing team here.